España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Windtree Therapeutics
WINT
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$3.76
0.05
1.35%
Pre-Market: Jul 12, 4:54 PM EDT
15 minutes delayed
Get Report
Watch
Windtree Therapeutics (WINT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Windtree Therapeutics (NASDAQ:WINT) Stock
Windtree Therapeutics Stock (NASDAQ: WINT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Windtree Therapeutics, On June 26, 2024, Ente...
Benzinga Newsdesk
Tuesday, May 07, 2024
Windtree Therapeutics Regains Compliance With...
Benzinga Newsdesk
Tuesday, April 23, 2024
(WINT) - Analyzing Windtree Therapeutics's Short Interest
Benzinga Insights
Monday, April 22, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Thursday, April 18, 2024
Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
Henry Khederian
Windtree Therapeutics shares are trading lowe...
Benzinga Newsdesk
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Windtree Therapeutics Announces 1-for-18 Reve...
Benzinga Newsdesk
Wednesday, April 17, 2024
Windtree Therapeutics Q4 2023 GAAP EPS $(0.95...
Benzinga Newsdesk
Tuesday, April 09, 2024
Windtree Therapeutics shares are trading lowe...
Benzinga Newsdesk
Monday, April 08, 2024
Windtree Enter Asset Purchase Agreement With ...
Benzinga Newsdesk
Friday, February 02, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, January 31, 2024
Windtree Therapeutics Engages Strategic Advis...
Benzinga Newsdesk
Monday, January 29, 2024
Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
Johnny Rice
Friday, January 26, 2024
Windtree Therapeutics Eliminates $15M Conting...
Benzinga Newsdesk
Thursday, January 25, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Rachael Green
-
Sponsored
Windtree Eliminates $15M Contingent Liability...
Benzinga Newsdesk
Friday, January 19, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Windtree Therapeutics To Develop And Commerci...
Benzinga Newsdesk
Wednesday, January 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
Meg Flippin
-
Sponsored
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Windtree Therapeutics Entered Into An Agreeme...
Charles Gross
Wednesday, January 03, 2024
Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
Meg Flippin
-
Sponsored
Tuesday, January 02, 2024
Windtree Therapeutics Announces Preclinical D...
Benzinga Newsdesk
Monday, December 18, 2023
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
Rachael Green
-
Sponsored
Windtree Therapeutics Starts Patient Dosing I...
Benzinga Newsdesk
Thursday, November 16, 2023
Windtree Therapeutics Announced That The Euro...
Benzinga Newsdesk
Thursday, November 09, 2023
Windtree Therapeutics Q3 EPS $(0.86) Misses $...
Benzinga Newsdesk
Tuesday, October 10, 2023
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, October 09, 2023
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, August 23, 2023
Windtree Reports Issuance Of Composition Of M...
Benzinga Newsdesk
Wednesday, August 16, 2023
Windtree Therapeutics Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
Happy Mohamed
Tuesday, August 15, 2023
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
David Willey
-
Sponsored
Monday, August 07, 2023
Windtree Therapeutics Q2 EPS $(1.64) Up From ...
Benzinga Newsdesk
Monday, July 24, 2023
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
David Willey
-
Sponsored
Monday, July 17, 2023
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
David Willey
-
Sponsored
Friday, July 14, 2023
Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
Johnny Rice
Wednesday, July 12, 2023
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
David Willey
-
Sponsored
Thursday, June 08, 2023
Top 10 Reddit Short Squeeze Mentions: for Thu...
Charles Gross
Tuesday, June 06, 2023
Windtree Therapeutics shares are trading high...
Benzinga Newsdesk
Windtree Therapeutics Granted European Patent...
Benzinga Newsdesk
Thursday, May 25, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, May 15, 2023
Windtree Therapeutics Q1 EPS $(4.76) Up From ...
Benzinga Newsdesk
Thursday, April 27, 2023
Windtree Therapeutics Announces Publication From Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime
Happy Mohamed
Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch